Healthcare Biotechnology

Regular price €210.80
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
A01=Dimitris Dogramatzis
advanced biomanufacturing operations
Age Group_Uncategorized
Age Group_Uncategorized
alliance strategy in biotech
Author_Dimitris Dogramatzis
automatic-update
Big Pharma
Big Pharmas
Biodrug Research
Bioeconomy
Biolicensing
Biomanufacturing
biomedical technology administration
biopharmaceutical commercialization
Biopharmaceutical Industry
Biopharmaceutical Product
biosimilar development
biotechnology industries
BLA
Category1=Non-Fiction
Category=KC
Category=KJM
Category=KJVN
Category=KND
Category=MBP
Category=PS
Category=TCB
Category=TDCW
clinical trial management
Contract Research Organizations
COP=United States
CVS Caremark
Delivery_Delivery within 10-20 working days
drug approval process
DTC Advertising
Early Stage Deal
eq_bestseller
eq_business-finance-law
eq_isMigrated=0
eq_isMigrated=2
eq_nobargain
eq_non-fiction
Gene Therapy Medicinal Products
Government Printing Office
GPC Biotech
Healthcare Biotechnology
Higher Treatment Response Rates
IMS Health
IMS Health Data
Intellectual Property High Court
Intellectual Property Management
ISIS Pharmaceutical
Language_English
Orphan Drug
PA=Available
Patent Expiration
pharmaceutical biotechnology
Price_€100 and above
Product's Competitive Advantages
PS=Active
Recombinant DNA
regulatory affairs
Segment Strategies
Small EU Member States
softlaunch
Specialty Pharmacy

Product details

  • ISBN 9781439847466
  • Weight: 1176g
  • Dimensions: 156 x 234mm
  • Publication Date: 14 Dec 2010
  • Publisher: Taylor & Francis Inc
  • Publication City/Country: US
  • Product Form: Hardback
  • Language: English
Secure checkout Fast Shipping Easy returns

Foreseeing and planning for all of the possibilities and pitfalls involved in bringing a biotechnology innovation from inception to widespread therapeutic use takes strong managerial skills and a solid grounding in biopharmaceutical research and development procedures. Unfortunately there has been a dearth of resources for this aspect of the field. Until now.

Focusing on the management of healthcare-related biotech, from conception through the product’s regulatory approval and entire life cycle, Healthcare Biotechnology: A Practical Guide provides a practical, applicable resource to assist all health-care related biotech professionals in their day-to-day activities from the lab to the boardroom.

Divided into six sections, the book begins with current systems and recent progress and controversy, major players and products, and a comparison with the pharmaceutical industry. It covers intellectual property protection and management, the innovation cycle, patent application, commercialization, and competition.

Coverage includes funding, partnering, cash-intensive activities, financing alternatives, and the complexities of alliance implementation and management. It highlights research, development, and biomanufacturing; and examines clinical trial design and regulations; "fast-track" approvals; and patient recruitment as well as production platforms and processes, costs, strategies, and timelines.

It investigates marketing including planning, promotion, pricing, supply chain management, and bio-brand lifecycle management. It concludes with tips on running the business, offering diverse biobusiness models and reasonable expectations from inception through maturity and decline.

An indispensible guide, this book offers more than 40 figures, 220 tables, and 180 references as well as a list of abbreviations and a business plan outline. Each chapter contains 10 questions to reinforce the material covered and 10 exercises

Dr. Dimitris Dogramatzis was born in Greece in 1962. After earning a Bachelor's diploma in Pharmacy from the University of Patras in Greece, he spent the next seven years in Texas studying and working for the University of Texas system. During this period, he completed his Ph.D. in Pharmacology and Toxicology at the University of Texas Medical Branch at Galveston. Later he went on to complete two successive postdoctoral trainings at the University of Texas Medical Branch at Galveston, as well as at the M.D. Anderson Cancer Center at Houston, Texas. He is currently the owner of a retail pharmacy in Athens, a business consultant, and a writer.

More from this author